{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:45:01Z","timestamp":1791305101356,"version":"4.3.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100019593","name":"Saluda Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s40122-024-00631-4","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T03:49:30Z","timestamp":1720496970000},"page":"1173-1185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Identifying SCS Trial Responders Immediately After Postoperative Programming with ECAP Dose-Controlled Closed-Loop Therapy"],"prefix":"10.1007","volume":"13","author":[{"given":"Jason E.","family":"Pope","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Antony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika A.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawood","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey W.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan H.","family":"Goree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau M.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harjot S.","family":"Bhandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Shumsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Bromberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Lawson","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Khurram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean M.","family":"Karantonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Deer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"issue":"6","key":"631_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/rapm-2022-104097","volume":"48","author":"H Shanthanna","year":"2023","unstructured":"Shanthanna H, Eldabe S, Provenzano DA, Bouche B, Buchser E, Chadwick R, et al. Evidence-based consensus guidelines on patient selection and trial stimulation for spinal cord stimulation therapy for chronic non-cancer pain. Reg Anesth Pain Med. 2023;48(6):273\u201387.","journal-title":"Reg Anesth Pain Med"},{"key":"631_CR2","unstructured":"Food and Drug Administration. Medtronic, Inc.; Premarket approval of the Medtronic Itrel spinal cord stimulation system. 1984."},{"key":"631_CR3","unstructured":"FDA. Conduct a trial stimulation period before implanting a spinal cord stimulator (SCS)\u2014letter to health care providers [Internet]. FDA. 2020 [cited 2023 Jan 3]. Available from: https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/conduct-trial-stimulation-period-implanting-spinal-cord-stimulator-scs-letter-health-care-providers"},{"key":"631_CR4","doi-asserted-by":"crossref","unstructured":"Thomson SJ, Tavakkolizadeh M, Love-Jones S, Patel NK, Gu JW, Bains A, et al. Effects of rate on analgesia in kilohertz frequency spinal cord stimulation: results of the PROCO randomized controlled trial. Neuromodul Technol Neural Interface 2018;21(1):67\u201376.","DOI":"10.1111\/ner.12746"},{"issue":"3","key":"631_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/17434440.2021.1890580","volume":"18","author":"CS Metzger","year":"2021","unstructured":"Metzger CS, Hammond MB, Paz-Solis JF, Newton WJ, Thomson SJ, Pei Y, et al. A novel fast-acting sub-perception spinal cord stimulation therapy enables rapid onset of analgesia in patients with chronic pain. Expert Rev Med Devices. 2021;18(3):299\u2013306.","journal-title":"Expert Rev Med Devices"},{"key":"631_CR6","doi-asserted-by":"crossref","unstructured":"North R, Desai MJ, Vangeneugden J, Raftopoulos C, Van Havenbergh T, Deruytter M, et al. Postoperative infections associated with prolonged spinal cord stimulation trial duration (PROMISE RCT). Neuromodul Technol Neural Interf. 2020;23(5):620\u20135.","DOI":"10.1111\/ner.13141"},{"issue":"4","key":"631_CR7","first-page":"843","volume":"134","author":"V Goel","year":"2022","unstructured":"Goel V, Kumar V, Patwardhan AM, Ibrahim M, Sivanesan E, Darrow D, et al. Procedure-related outcomes including readmission following spinal cord stimulator implant procedures: a retrospective cohort study. Anesth Analg. 2022;134(4):843\u201352.","journal-title":"Anesth Analg"},{"key":"631_CR8","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.2147\/JPR.S378937","volume":"15","author":"RH Jenkinson","year":"2022","unstructured":"Jenkinson RH, Wendahl A, Zhang Y, Sindt JE. Migration of pidural leads during spinal cord stimulator trials. J Pain Res. 2022;15:2999\u20133005.","journal-title":"J Pain Res"},{"issue":"9","key":"631_CR9","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1093\/pm\/pnx305","volume":"19","author":"H Khan","year":"2018","unstructured":"Khan H, Kumar V, Ghulam-Jelani Z, McCallum SE, Hobson E, Sukul V, et al. Safety of spinal cord stimulation in patients who routinely use anticoagulants. Pain Med. 2018;19(9):1807\u201312.","journal-title":"Pain Med"},{"issue":"12","key":"631_CR10","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1097\/j.pain.0000000000001977","volume":"161","author":"S Eldabe","year":"2020","unstructured":"Eldabe S, Duarte RV, Gulve A, Thomson S, Baranidharan G, Houten R, et al. Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness (TRIAL-STIM)? A randomised controlled trial. Pain. 2020;161(12):2820\u20139.","journal-title":"Pain"},{"key":"631_CR11","unstructured":"Center for Devices and Radiological Health. Technical considerations for medical devices with physiologic closed-loop control technology [Internet]. FDA; 2023 [cited 2023 Nov 5]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/technical-considerations-medical-devices-physiologic-closed-loop-control-technology"},{"issue":"3","key":"631_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1001\/jamaneurol.2021.4998","volume":"79","author":"N Mekhail","year":"2022","unstructured":"Mekhail N, Levy RM, Deer TR, Kapural L, Li S, Amirdelfan K, et al. Durability of clinical and quality-of-life outcomes of closed-loop spinal cord stimulation for chronic back and leg pain: a secondary analysis of the EVOKE randomized clinical trial. JAMA Neurol. 2022;79(3):251\u201360.","journal-title":"JAMA Neurol"},{"issue":"2","key":"631_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1474-4422(19)30414-4","volume":"19","author":"N Mekhail","year":"2020","unstructured":"Mekhail N, Levy RM, Deer TR, Kapural L, Li S, Amirdelfan K, et al. Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (EVOKE): a double-blind, randomised, controlled trial. Lancet Neurol. 2020;19(2):123\u201334.","journal-title":"Lancet Neurol"},{"key":"631_CR14","doi-asserted-by":"crossref","unstructured":"Mekhail NA, Levy RM, Deer TR, Kapural L, Li S, Amirdelfan K, et al. ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial. Reg Anesth Pain Med. 2024;49(5):346\u201354.","DOI":"10.1136\/rapm-2023-104751"},{"key":"631_CR15","doi-asserted-by":"crossref","unstructured":"Kapural L, Mekhail NA, Costandi S, Gilmore C, Pope JE, Li S, et al. Durable multimodal and holistic response for physiologic closed-loop spinal cord stimulation supported by objective evidence from the EVOKE double-blind randomized controlled trial. Reg Anesth Pain Med. 2023;rapm-2023\u2013104639.","DOI":"10.1136\/rapm-2023-104639"},{"key":"631_CR16","doi-asserted-by":"crossref","unstructured":"Duarte RV, Bentley A, Soliday N, Leitner A, Gulve A, Staats PS, et al. Cost-utility analysis of Evoke closed-loop spinal cord stimulation for chronic back and leg pain. Clin J Pain. 2023;39(10):551\u20139.","DOI":"10.1097\/AJP.0000000000001146"},{"key":"631_CR17","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.2147\/JPR.S411927","volume":"16","author":"A Leitner","year":"2023","unstructured":"Leitner A, Hanson E, Soliday N, Staats P, Levy R, Pope J, et al. Real world clinical utility of neurophysiological measurement utilizing closed-loop spinal cord stimulation in a chronic pain population: the ECAP Study protocol. JPR. 2023;16:2497\u2013507.","journal-title":"JPR"},{"key":"631_CR18","doi-asserted-by":"crossref","unstructured":"Hagedorn JM, Bendel MA, Schmidt A, Schroeder DR, Hooten WM. Comparison of spinal cord stimulation trial reporting protocols and long-term pain relief outcomes following implantation. Neuromodul Technol Neural Interface. 2023;26(5):1047\u201350.","DOI":"10.1016\/j.neurom.2022.01.022"},{"issue":"4","key":"631_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/rapm-2020-102238","volume":"46","author":"JM Hagedorn","year":"2021","unstructured":"Hagedorn JM, Deer TR, Canzanello NC, Covington SM, Schroeder DR, Bendel MA, et al. Differences in calculated percentage improvement versus patient-reported percentage improvement in pain scores: a review of spinal cord stimulation trials. Reg Anesth Pain Med. 2021;46(4):293\u20137.","journal-title":"Reg Anesth Pain Med"},{"issue":"2","key":"631_CR20","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/neurolint15020034","volume":"15","author":"AB Fink","year":"2023","unstructured":"Fink AB, Ong C, Sumar MK, Patel NC, Knezevic NN. The discrepancy and agreement between patient-reported percentage pain reduction and calculated percentage pain reduction in chronic pain patients. Neurol Int. 2023;15(2):560\u20138.","journal-title":"Neurol Int"},{"issue":"16","key":"631_CR21","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1097\/00007632-200008150-00015","volume":"25","author":"P Stratford","year":"2000","unstructured":"Stratford P, Binkley JM, Riddle DL. Development and initial validation of the back pain functional scale. Spine. 2000;25(16):2095\u2013102.","journal-title":"Spine"},{"issue":"1","key":"631_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2519\/jospt.2012.3727","volume":"42","author":"KK Horn","year":"2012","unstructured":"Horn KK, Jennings S, Richardson G, van Vliet D, Hefford C, Abbott JH. The patient-specific functional scale: psychometrics, clinimetrics, and application as a clinical outcome measure. J Orthop Sports Phys Ther. 2012;42(1):30\u201340.","journal-title":"J Orthop Sports Phys Ther"},{"issue":"4","key":"631_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3138\/ptc.47.4.258","volume":"47","author":"P Stratford","year":"1995","unstructured":"Stratford P, Gill C, Westaway M, Binkley JM. Assessing disability and change on individual patients: a report of a patient specific measure. Physiother Can. 1995;47(4):258\u201363.","journal-title":"Physiother Can"},{"key":"631_CR24","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1109\/TNSRE.2023.3335100","volume":"31","author":"PS Single","year":"2023","unstructured":"Single PS, Scott JB, Mugan D. Measures of dosage for spinal-cord electrical stimulation: review and proposal. IEEE Trans Neural Syst Rehabil Eng. 2023;31:4653\u201360.","journal-title":"IEEE Trans Neural Syst Rehabil Eng"},{"key":"631_CR25","doi-asserted-by":"crossref","unstructured":"Muller L, Pope J, Petersen E, Verrills P, Kallewaard JW, Gould I, et al. First evidence of a biomarker-based dose-response relationship in chronic pain using physiologic closed-loop spinal cord stimulation. Reg Anesth Pain Med. 2024; rapm-2024-105346.","DOI":"10.1136\/rapm-2024-105346"},{"key":"631_CR26","doi-asserted-by":"crossref","unstructured":"Mekhail NA, Levy RM, Deer TR, Kapural L, Li S, Amirdelfan K, et al. Neurophysiological outcomes that sustained clinically significant improvements over 3 years of physiologic ECAP-controlled closed-loop spinal cord stimulation for the treatment of chronic pain. Reg Anesth Pain Med. 2024; rapm-2024-105370.","DOI":"10.1136\/rapm-2024-105370"},{"key":"631_CR27","doi-asserted-by":"crossref","unstructured":"Deer TR, Narouze S, Provenzano DA, Pope JE, Falowski SM, Russo MA, et al. The Neurostimulation Appropriateness Consensus Committee (NACC): recommendations on bleeding and coagulation management in neurostimulation devices. Neuromodul Technol Neural Interf. 2017;20(1):51\u201362.","DOI":"10.1111\/ner.12542"},{"issue":"3","key":"631_CR28","first-page":"225","volume":"43","author":"S Narouze","year":"2018","unstructured":"Narouze S, Benzon HT, Provenzano D, Buvanendran A, De Andres J, Deer T, et al. Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications (Second Edition): guidelines From the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med. 2018;43(3):225\u201362.","journal-title":"Reg Anesth Pain Med"},{"key":"631_CR29","doi-asserted-by":"crossref","unstructured":"Chadwick R, McNaughton R, Eldabe S, Baranidharan G, Bell J, Brookes M, et al. To trial or not to trial before spinal cord stimulation for chronic neuropathic pain: the patients\u2019 view from the TRIAL-STIM randomized controlled trial. Neuromodul Technol Neural Interf. 2021;24(3):459\u201370.","DOI":"10.1111\/ner.13316"},{"issue":"5","key":"631_CR30","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.neurom.2023.03.016","volume":"26","author":"T West","year":"2023","unstructured":"West T, ElSaban M, Hussain N, Schappell J, Rogers K, Orhurhu V, et al. Incidence of lead migration with loss of efficacy or paresthesia coverage after spinal cord stimulator implantation: systematic review and proportional meta-analysis of prospective studies and randomized clinical trials. Neuromodulation. 2023;26(5):917\u201327.","journal-title":"Neuromodulation"},{"issue":"3","key":"631_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1049\/htl.2019.0110","volume":"7","author":"J Parker","year":"2020","unstructured":"Parker J, Karantonis D, Single P. Hypothesis for the mechanism of action of ECAP-controlled closed-loop systems for spinal cord stimulation. Healthc Technol Lett. 2020;7(3):76\u201380.","journal-title":"Healthc Technol Lett"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-024-00631-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-024-00631-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-024-00631-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T12:48:44Z","timestamp":1726145324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-024-00631-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["631"],"URL":"https:\/\/doi.org\/10.1007\/s40122-024-00631-4","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"7 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jason E. Pope reports research and consulting fees from Saluda Medical during the conduct of the study; consultancy for Abbott, Medtronic, Saluda Medical, Flowonix, SpineThera, Vertos, Vertiflex, SPR Therapeutics, Tersera, Aurora, Spark, Ethos, Biotronik, Mainstay, WISE, Boston Scientific, and Thermaquil outside the submitted work; has received grant and research support from: Abbott, Flowonix, Aurora, Painteq, Ethos, Muse, Boston Scientific, SPR Therapeutics, Mainstay, Vertos, AIS, and Thermaquil outside the submitted work; and is a minority shareholder of Vertos, Stimgenics, SPR Therapeutics, Saluda Medical, Painteq, Aurora, Spark, Celeri Health, Neural Integrative Solutions, Pacific Research Institute, Thermaquil, Abbott and Anesthetic Gas Reclamation. Ajay Antony serves as a consultant\/speaker for Boston Scientific, Abbott, Nalu, PainTEQ, Saluda, Vertos; he has received research support from ViaDISC, Abbott, Boston scientific, PainTEQ, Saluda, and SPR. Erika A. Petersen has received research support from Mainstay, Medtronic, Neuros Medical, Nevro Corp, ReNeuron, SPR, and Saluda Medical outside the submitted work, as well as personal fees from Abbott Neuromodulation, Biotronik, Medtronic Neuromodulation, Nalu, Neuros Medical, Nevro, Presidio Medical, Saluda Medical, and Vertos outside the submitted work. She holds stock options from SynerFuse and neuro42. There are no other relationships that might lead to a conflict of interest in the current study. Steven M. Rosen reports research and consulting fees from Saluda Medical during the conduct of the study. Dawood Sayed reports personal fees from Abbott, Boston Scientific, Flowonix, Medtronic, Nevro, Saluda, and Vertiflex, personal fees and stock options from Mainstay, SPR Therapeutics, PainTEQ, and Vertos, and stock options from Neuralace and Surgentec. Corey W. Hunter reports grants from Saluda Medical during the conduct of the study and consultancy fees from Genecentrix outside the submitted work. Johnathan H. Goree is a consultant for Saluda Medical, Abbott, and Stratus Medical and the recipient of research support paid to the institution by SPR Therapeutics and Mainstay Medical. Chau M. Vu serves as a consultant for Saluda Medical; consultant and principal investigator for PainTEQ. Harjot S. Bhandal serves as a consultant for Saluda Medica and principal investigator for Aurora Spine.\u00a0Philip M. Shumsky serves as a consultant for Saluda Medical. Todd A. Bromberg reports research and consulting fees from Saluda Medical during the conduct of the study. He is also an advisor for and reports research fees from Medtronic. G. Lawson Smith and Christopher M. Lam report no conflicts of interest. Hemant Kalia serves as a consultant for Abbott, Nevro, Nalu, SPR Therapeutics, and Curonix. He serves on the medical advisory board for Abbott, Equanimity, Nervonik, and Virdio Health and reports research support from Abbott. Jennifer M. Lee is a consultant for and has received research support from Boston Scientific. Abeer Khurram, Ian Gould, and Dean M. Karantonis report being employees of Saluda Medical. Timothy R. Deer reports personal fees from Saluda Medical during the conduct of the study and consultancy for Axonics, Abbott, Nalu, Vertos, SpineThera, Mainstay, CornerLoc, Ethos, SPR Therapeutics, Medtronic, Boston Scientific, PainTEQ, Tissue Tech, Spinal Simplicity, and Avanos outside the submitted work. He is a minor equity holder of Saluda Medical, Nalu, SpineThera, Stimgenics, Vertiflex, Vertos, and Bioness and an advisory board member of Abbott, Vertos, Nalu, SPR Therapeutics, and Tissue Tech.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"All subjects gave their informed consent for inclusion before they participated in the ECAP Study (NCT04319887, registered 24\u00a0March\u00a02020 on ClinicalTrials.gov, first enrollment 29\u00a0October\u00a02020). The ECAP Study was conducted in accordance with the United States Food and Drug Administration (FDA) regulatory requirements, good clinical practice (GCP, per ISO 14155), Western Institutional Review Board approval (WIRB), and the Declaration of Helsinki guided ethical principles.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}